Search

Introduction: Differences in time commitments and resources contribute to the difficulties of work-life integration for many physician-scientists, particularly for women with family caregiving responsibilities. Understanding the challenges faced by this population is critical for the retention of these critical members of the workforce. Methods: We conducted semi-structured telephone interviews with recipients of the 2017 Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists (FRCS) and reviewed application narratives from the 2020 award recipients. Award recipients were asked about their caregiving responsibilities and careers, particularly as they related to the impact of the FRCS award and the aftereffects of the COVID-19 pandemic. Analysts then iteratively revised the coding scheme and interpreted the data using qualitative thematic analysis. Results: Of the 14 interviewees and 19 narrative contributors, 25 (76%) were women. The main qualitative themes that emerged were as follows: (1) women experience unrealistically high caregiving burdens, (2) women are overburdened by disadvantageous and undervalued expectations at work, (3) work-life expectations increased during the COVID-19 pandemic, and (4) unrealistic work-life expectations led to guilt and burnout. Conclusions: These findings provide a rich understanding of the factors contributing to guilt and burnout among physician-scientists, particularly women, and how work duties that increase physician obligations exacerbated these challenges. Understanding these experiences is critical to supporting and retaining a diverse workforce in academic medicine.

Purpose: Financial toxicity from cancer treatment is a growing concern. Its impact on patients requires refining our understanding of this phenomenon. We sought to characterize patients' experiences of financial toxicity in the context of an established framework to identify knowledge gaps and strategies for mitigation., Methods: Semistructured interviews with patients with breast cancer who received financial aid from a philanthropic organization during treatment were conducted from February to May 2020. Interviews were transcribed and coded until thematic saturation was reached, and findings were contextualized within an existing financial toxicity framework., Results: Thirty-two patients were interviewed, of whom 58% were non-Hispanic White. The mean age was 46 years. Diagnoses ranged from ductal carcinoma in situ to metastatic breast cancer. Concordant with an established framework, we found that direct and indirect costs determined objective financial burden and subjective financial distress stemmed from psychosocial, behavioral, and material impact of diagnosis and treatment. We identified expectations as a novel theme affecting financial toxicity. We identified knowledge gaps in treatment expectations, provider conversations, identification of resources, and support-finding and offer strategies for mitigating financial toxicity on the basis of participant responses, such as leveraging support from decision aids and allied providers., Conclusion: This qualitative study confirms an existing framework for understanding financial toxicity and identifies treatment expectations as a novel theme affecting both objective financial burden and subjective financial distress. Four knowledge gaps are identified, and strategies for mitigating financial toxicity are offered. Mitigating patients' financial toxicity is an important unmet need in optimizing cancer treatment., Competing Interests: Susan GooldPatents, Royalties, Other Intellectual Property: A simulation exercise (CHAT) I coinvented, when others pay to use it, results in royalties to me, my coinventor, and our institutions. My own royalty receipts in the past 2 years have been less than $1,000 US dollars Grace SmithResearch Funding: Varian Medical SystemsOther Relationship: Oncora Medical Reshma JagsiEmployment: University of MichiganStock and Other Ownership Interests: Equity QuotientResearch Funding: GenentechExpert Testimony: Baptist Health/Dressman Benziger Lavalle Law, Kleinbard LLCTravel, Accommodations, Expenses: AmgenOther Relationship: JAMA OncologyOpen Payments Link: https://openpaymentsdata.cms.gov/physician/373670/summaryhttps://openpaymentsdata.cms.gov/physician/373670/summaryNo other potential conflicts of interest were reported.

This column presents results of a pay-for-performance (P4P) initiative to reduce psychiatric inpatient length of stay for Medicaid-covered youths at eight hospitals in Connecticut in 2008 (N=715), 2009 (N=1,408), and 2010 (N=782). Compared with the 2007 baseline, average length of stay decreased by 25% (from 18.1 to 13.6 days) by the end of the P4P program, with concurrent nonsignificant decreases in 7- and 30-day readmissions. Readmitted youths tended to access postdischarge care sooner and use more community-based services during the first 180 days postdischarge. Additional research is needed, but the P4P program appears to have contributed to shortening inpatient stay without apparent adverse outcome on increases in postdischarge service use.